CliffBio
small molecule

EVOMELA

MELPHALAN HYDROCHLORIDE

Loss of exclusivityJanuary 2034latest FDA-listed patent expiry
CompanyAcrotech Biopharma →View the full company profile on CliffBio

Drug detail

Brand nameEVOMELA
Active ingredientMELPHALAN HYDROCHLORIDE
StrengthEQ 50MG BASE/VIAL
Dosage formPOWDER
RouteINTRAVENOUS
ModalitySmall molecule
FDA approvalMarch 2016
Marketing statusRX

Listed patents

PatentExpiresType
10040872January 2034product
9493582February 2033product
10940128June 2030product
11020363May 2030product
10864183May 2030product
9200088March 2029product
8410077March 2029product

More from Acrotech Biopharma

Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the latest FDA-listed patent expiry; estimates are projections, not legal advice.

EVOMELA patent cliff — loss of exclusivity January 2034 | CliffBio